Inventor · Mill Creek, WA, US

Alisha K. Weight

11Patents
2h-index
5Co-inventors
39Inventor score

Filing activity: Sep 11, 2014 → Oct 19, 2020

Most-cited inventions

PatentTitleAreaCited byStatus
US9913905B2 Liquid pharmaceutical formulations for injection comprising thiamine pyrophosphate 1-(3-aminopropyl)-2-methyl-1H-imidazole and uses thereof Emerging Cross-Sectional Technologies 3 Active
US9833513B2 Liquid protein formulations for injection comprising 1-butyl-3-methylimidazolium methanesulfonate and uses thereof Emerging Cross-Sectional Technologies 3 Active
US9925263B2 Liquid pharmaceutical formulations for injection comprising procaine and uses thereof Emerging Cross-Sectional Technologies 2 Active
US10849977B2 Liquid Protein Formulations Containing Thiamine Emerging Cross-Sectional Technologies 1 Active
US10821184B2 Liquid protein formulations containing thiamine pyrophosphate (TPP) Emerging Cross-Sectional Technologies 1 Active
US10179172B2 Liquid pharmaceutical formulations for injection comprising yellow 5 or orange G and uses thereof Emerging Cross-Sectional Technologies 1 Active
US11471479B2 Polysaccharide and nucleic acid formulations containing viscosity-lowering agents Human Necessities 1 Active
US10821183B2 Liquid protein formulations containing 4-(3-butyl-1-imidazolio)-1-butane sulfonate (BIM) Emerging Cross-Sectional Technologies 0 Active
US11986526B2 Liquid protein formulations containing 4-ethyl-4-methylmorpholinium methylcarbonate (EMMC) Emerging Cross-Sectional Technologies 0 Active
US11819550B2 Liquid protein formulations containing cyclic adenosine monophosphate (cAMP) or adenosine triphosphate (ATP) Emerging Cross-Sectional Technologies 0 Active
US10646571B2 Liquid protein formulations containing cimetidine Emerging Cross-Sectional Technologies 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.